MorphoSys AG has reached a licensing agreement with the St Louis Missouri-based life science company, Sigma-Aldrich under which the German company will develop and qualify antibodies from its proprietary antibody library against targets supplied by Sigma-Aldrich. Financial details were not disclosed.
